Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study - Wikidata - wikimedia - TriplyDB

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

http://www.wikidata.org/entity/Q34644993

about

Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement Treating the elderly diabetic patient: special considerations Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors Practical combination therapy based on pathophysiology of type 2 diabetes Understanding and overcoming metformin gastrointestinal intolerance.Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.Validation of methods for assessing cardiovascular disease using electronic health data in a cohort of Veterans with diabetes.Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.Evaluation of patient-reported outcomes data in structured diabetes education intervention: 2-year follow-up data of patient empowerment programme.Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.Use of cystatin C to inform metformin eligibility among adult veterans with diabetes.Metformin in peritoneal dialysis: a pilot experience American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women.Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes Cardiovascular safety profile of currently available diabetic drugs.Time to be cautious about prescribing sulfonylureas?Thiazolidinedione and Metformin Use and the Risk of Benign Prostate Hyperplasia in Veterans with Diabetes Mellitus.Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse Cost effectiveness of dipeptidyl peptidase-4 inhibitors for type 2 diabetes.Reduced vascular events in type 2 diabetes by biguanide relative to sulfonylurea: study in a Japanese Hospital Database.Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility.Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention The influence of hypoglycemic drugs on exercise-mediated hypoglycemic effects in elderly type 2 diabetic patients.Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine.Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life Span.Case-control study of oral glucose-lowering drugs in combination with long-acting insulin and the risks of incident myocardial infarction and incident stroke Falsification Testing of Instrumental Variables Methods for Comparative Effectiveness Research Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis.Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study.Observational research--opportunities and limitations.Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes.

P2860

Q22241119-FCB50760-45A4-454A-ADAF-B4C88473F25A Q24185970-001CAC09-CEF6-4605-B4B3-5B6CFC268B81 Q26740253-5B7F6339-6496-45D8-AB07-6DB30A202C4C Q26748870-A37DA6E7-DC2B-473B-BDFC-61C5A1479DF3 Q26783199-BCEC7DCD-64D1-442C-B0B3-79377076C2F9 Q26995176-7619561E-BB49-434A-B71A-BCDE8085DE65 Q27021870-E2603DD6-F020-46F2-BAFF-4D1DC1B40C3F Q28076530-7FEAB373-5964-4AC5-AE3B-38B9DBC7DD09 Q30240030-BFABE8F4-AD92-45D4-93C6-A29FF74FBF7F Q30243879-EA570BA8-3161-478D-ACAB-041991ABC445 Q30740532-5264D6EB-4461-4488-AF64-F78BE71337D5 Q31095975-5C8BB851-06B2-46CD-9D0F-310682495E73 Q31130301-0D131A9A-60A8-462B-9288-216C0298246A Q33705903-FAF483F8-7813-4008-BEB0-4C96E5DD0479 Q33778097-D5D4E53B-0A26-478F-A3C0-54F56A53512A Q33837650-5F2B5FAE-8755-41E7-9CE0-97A8562731BE Q34081331-380ED2D4-D2A5-4145-8E41-F2F6169C5089 Q34109319-3F1F8457-BFC5-49E8-A5F3-22B00414E4DE Q34392375-1562D0B3-3564-47C8-9C86-4383333EC144 Q34684420-959D7060-64AA-48C2-A617-9A8CE1C05E8C Q34971736-F21B1EF6-774C-43C8-A2C2-B3C85FD039A7 Q35076020-5745DE77-DCE5-4676-BA88-246948125B9B Q35190607-66F299FA-7920-4F66-A8D4-1333A5B6A6B7 Q35498269-B8248CE7-A074-46E0-800B-E9568ED649B3 Q35570938-EC677493-6B16-4910-AB54-BA0DC7876CAA Q35780117-72127717-3D23-4D55-A294-3669BF2E56BD Q35877249-78E63475-96AD-44D4-9F42-97D9A29039E2 Q35894680-D76B35FB-A345-4BD3-AE55-0DDD07955C27 Q36038607-8C81FD5E-979B-4688-8F3D-CDF355B97083 Q36080332-6DDFB79A-DFD9-4CEA-A8F5-164259BC0626 Q36183455-63E66500-5065-46BE-9EA4-80357B4E4BF1 Q36185994-0CC0E6D8-3C21-4E33-B6AF-F1538B5FEFDE Q36406255-5E8C66C0-7B8F-4615-87CE-FE992846195D Q36520595-4C6A1857-48CE-48A6-ACA6-6AF56A9012E3 Q36706682-06ED9F9F-2C7E-4BBC-B53D-1336000730AB Q36757698-0973A767-C573-4865-BC43-077BCE5E481C Q36836016-54C4CBAA-FBA3-47E9-82FF-D6E09505EFCD Q37133779-7FD623EB-D62C-4BB2-8464-3DB14E517DE0 Q37282191-8CE55AA4-E644-4011-B33F-2BF886176046 Q37577162-BB6D7897-885E-436C-B129-018DEBF21030

P2860

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

http://www.wikidata.org/entity/Q34644993

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Comparative effectiveness of s ...... betes mellitus: a cohort study

@ast

Comparative effectiveness of s ...... betes mellitus: a cohort study

@en

Comparative effectiveness of s ...... betes mellitus: a cohort study

@nl

type

label

Comparative effectiveness of s ...... betes mellitus: a cohort study

@ast

Comparative effectiveness of s ...... betes mellitus: a cohort study

@en

Comparative effectiveness of s ...... betes mellitus: a cohort study

@nl

prefLabel

Comparative effectiveness of s ...... betes mellitus: a cohort study

@ast

Comparative effectiveness of s ...... betes mellitus: a cohort study

@en

Comparative effectiveness of s ...... betes mellitus: a cohort study

@nl

P1433

Q34644993-E6DCCFCA-349B-4862-BA7E-56835B048823

P1476

Q34644993-6F10FCB9-35F6-47AC-8110-AE0A5B148C47

P2093

Q34644993-545F4B68-5EDA-4370-91D0-D011B45259D5

Q34644993-6B32993A-3B96-4CB1-A68A-4957901DB91B

Q34644993-775F2B54-4B8A-45C8-8701-380B16E56ACE

Q34644993-A74D57DB-7E79-4C0C-8762-26136C46991F

Q34644993-B1C4F370-36E1-48AB-9376-320B0A10CD1B

Q34644993-B8ECDFB9-93C9-43BB-9A69-2628AE8989FF

Q34644993-D7FBBA8F-E2BF-4A79-9938-6A8931DEF8E0

Q34644993-F10753DD-2DFB-4053-BB25-F3EFC92C986A

P2860

Q34644993-047817AF-01BE-45BE-A164-E720C97C8DB7

Q34644993-12A338D0-83DB-4A31-9256-32E5061E772E

Q34644993-158D5C10-F16D-4C82-99B6-1D1AAED96360

Q34644993-23A4D6F3-2507-4CE9-897D-CD52E95CA9ED

Q34644993-2E01F729-71C8-4F93-9F30-A81CBE955C67

Q34644993-3B3899DB-D6C3-4F60-8E74-41CDCC4D9427

Q34644993-47FF3F5E-B9ED-4501-AB74-F9DAA6B5E621

Q34644993-4F36DCEB-24A4-4200-9291-D3DA7545CB4F

Q34644993-523F6FDB-A42F-4337-A9E9-0186F8C03F02

Q34644993-57B902F1-7C49-4497-8327-8F8FEA658E0C

P304

Q34644993-9526D334-2271-4F77-B3E3-BE2A80E767C4

P31

Q34644993-779188E6-A47C-4C0A-8655-D63949BA930E

P356

Q34644993-965C03CB-C314-408E-B5C4-EFB15AAD17AB

P407

Q34644993-778248BC-9435-4CD6-869C-FA1AE09BE565

P433

Q34644993-AF2A864C-1B17-46D5-9F87-9DAE1F8824E8

P478

Q34644993-B4C2AB7E-5150-4996-B7FC-78DE61887C68

P577

Q34644993-980D4A56-2EA3-4832-A589-89BB0EF707DC

P5875

Q34644993-940420E2-2C44-4D22-9E87-6270AEE9C5B3

P698

Q34644993-BED3C9BA-3987-4E94-ABF1-BEAB9EC54B37

P921

Q34644993-85975418-E6CC-4AD8-97BC-063AEF9518FD

Q34644993-87CEF8A5-1491-4C61-AC86-C37C9BD41485

Q34644993-DC776DE7-9DAD-4C2A-887E-CFDC9FF1E3FA

P932

Q34644993-41140BBC-4AD7-4D88-82F1-B687EC1CFB90

P356

0003-4819-157-9-201211060-00003

P1433

Annals of Internal Medicine

P1476

Comparative effectiveness of s ...... betes mellitus: a cohort study

@en

P2093

Adriana M Hung

http://www.w3.org/2001/XMLSchema#string

Carlos G Grijalva

http://www.w3.org/2001/XMLSchema#string

Christianne L Roumie

http://www.w3.org/2001/XMLSchema#string

Harvey J Murff

http://www.w3.org/2001/XMLSchema#string

Marie R Griffin

http://www.w3.org/2001/XMLSchema#string

Robert A Greevy

http://www.w3.org/2001/XMLSchema#string

Tom A Elasy

http://www.w3.org/2001/XMLSchema#string

Xulei Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

Executive Summary: Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

National trends in treatment of type 2 diabetes mellitus, 1994-2007

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

P304

601-610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-157-9-201211060-00003

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232916176

http://www.w3.org/2001/XMLSchema#string

P698

23128859

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

type-2 diabetes

P932

4667563

http://www.w3.org/2001/XMLSchema#string